BioMarrow: An accessible and reproducible 3D patient-derived bone marrow model for advancing research and clinical applications
Translational Oncology · 2026-02 · 64 · 102643
DOI: 10.1016/j.tranon.2025.102643 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Oncology, 2026-02. Verfasst von Diana Lourenço und 7 weiteren Autor:innen. Beteiligte Einrichtung: Myeloma Lymphoma Research Group-Champalimaud Experimental Clinical Research Programme of Champalimaud Foundation, Lisbon 1400-038, Portugal. Electron…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fundação Champalimaud, Foundation for Science and Technology.
Abstract (Originalsprache)
Preclinical models for multiple myeloma (MM) often fail to recapitulate the complexity of the bone marrow (BM) microenvironment, limiting their utility for drug testing and translational research. There is an urgent need for physiologically relevant, patient-adaptable platforms to support personalized therapeutic evaluation. We developed BioMarrow, a 3D ex vivo BM culture system using unmanipulated patient BM aspirates embedded in Matrigel. Culture conditions were optimized to sustain diverse hematopoietic, stromal and immune populations for up to 7 days. Spatial distribution, cytokine secretion and treatment responses were assessed via flow cytometry, immunohistochemistry, multiplex ELISA and cell viability assays. The model maintained key BM components characteristics of MM, supported stromal network formation and preserved cytokines such as IL-6 and TGF-β. Immune-effector cytokines were reduced, consistent with a tumour-permissive microenvironment. Drug testing with MM cell lines confirmed BioMarrow's ability to discriminate treatment sensitivity. BioMarrow captures essential features of the MM niche and offers a clinically relevant, short-term platform for ex vivo therapeutic screening. Its scalability and immune component preservation support future integration into personalized treatment workflows, including immunotherapy evaluation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Myeloma Lymphoma Research Group-Champalimaud Experimental Clinical Research Programme of Champalimaud Foundation, Lisbon 1400-038, Portugal. Electronic address: diana.lourenco@research.fchampalimaud.org.
- Myeloma Lymphoma Research Group-Champalimaud Experimental Clinical Research Programme of Champalimaud Foundation, Lisbon 1400-038, Portugal; Faculty of Medicine, University of Lisbon, Lisbon 1649-028, Portugal. Electron…
- Hemato-Oncology Unit of Champalimaud Foundation, Lisbon 1400-038, Portugal. Electronic address: joana.caetano@research.fchampalimaud.org.
- Myeloma Lymphoma Research Group-Champalimaud Experimental Clinical Research Programme of Champalimaud Foundation, Lisbon 1400-038, Portugal; NOVA Medical School, NOVA University, Lisbon, Lisbon 1169-056, Portugal. Elect…
- Myeloma Lymphoma Research Group-Champalimaud Experimental Clinical Research Programme of Champalimaud Foundation, Lisbon 1400-038, Portugal. Electronic address: ana.queiros@research.fchampalimaud.org.
- Myeloma Lymphoma Research Group-Champalimaud Experimental Clinical Research Programme of Champalimaud Foundation, Lisbon 1400-038, Portugal. Electronic address: emilie.carneiro@research.fchampalimaud.org.
Förderung
- Fundação Champalimaud
- Foundation for Science and Technology
Zitieren
APA
Lourenço, D., Lopes, R., Caetano, J., Barahona, F., Rodrigues, J., Queirós, A. C., Carneiro, E. A., & João, C. (2026). BioMarrow: An accessible and reproducible 3D patient-derived bone marrow model for advancing research and clinical applications. Translational Oncology, 64, 102643. https://doi.org/10.1016/j.tranon.2025.102643
Vancouver
Lourenço D, Lopes R, Caetano J, Barahona F, Rodrigues J, Queirós AC, et al. BioMarrow: An accessible and reproducible 3D patient-derived bone marrow model for advancing research and clinical applications. Translational Oncology. 2026;64:102643. doi:10.1016/j.tranon.2025.102643
BibTeX
@article{Loureno2026,
author = {Lourenço, Diana and Lopes, Raquel and Caetano, Joana and Barahona, Filipa and Rodrigues, Jessica and Queirós, Ana C and Carneiro, Emilie Arnault and João, Cristina},
title = {BioMarrow: An accessible and reproducible 3D patient-derived bone marrow model for advancing research and clinical applications},
journal = {Translational Oncology},
year = {2026},
volume = {64},
pages = {102643},
doi = {10.1016/j.tranon.2025.102643}
}
EUVIMED